{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:13:14Z","timestamp":1790251994699,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.018","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T16:16:43Z","timestamp":1321546603000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Intradermal fractional dose inactivated polio vaccine: A review of the literature"],"prefix":"10.1016","volume":"30","author":[{"given":"Katherine S.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.vaccine.2011.11.018_bib0005","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N Engl J Med"},{"issue":"5802","key":"10.1016\/j.vaccine.2011.11.018_bib0010","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0015","unstructured":"PATH. Improving the affordability of inactivated poliovirus vaccines (IPV) for use in low- and middle-income countries: an economic analysis of strategies to reduce the cost of routine IPV immunization, April 2010. Program for Appropriated Technology in Health (PATH) and Working in Tandem Ltd."},{"issue":"8860","key":"10.1016\/j.vaccine.2011.11.018_bib0020","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.018_bib0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM200009143431103","article-title":"Trial of a supplemental dose of four poliovirus vaccines","volume":"343","author":"Sutter","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0030","series-title":"Vaccines","first-page":"631","article-title":"Poliovirus vaccine-live","author":"Sutter","year":"2008"},{"issue":"25","key":"10.1016\/j.vaccine.2011.11.018_bib0035","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.401","article-title":"Polio eradication: the OPV paradox","volume":"13","author":"Dowdle","year":"2003","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.018_bib0045","article-title":"Cost analysis of post-polio certification immunization policies","volume":"82","author":"Sangrujee","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"18","key":"10.1016\/j.vaccine.2011.11.018_bib0050","first-page":"582","article-title":"Progress toward interruption of wild poliovirus transmission \u2013 worldwide, January 2010\u2013March 2011","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Ann Rev Microbiol"},{"issue":"28","key":"10.1016\/j.vaccine.2011.11.018_bib0060","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/j.vaccine.2009.03.078","article-title":"Why polio has not been eradicated in india despite many remedial interventions?","volume":"27","author":"Paul","year":"2009","journal-title":"Vaccine"},{"issue":"09","key":"10.1016\/j.vaccine.2011.11.018_bib0065","first-page":"268","article-title":"Progress Toward Poliomyelitis Eradication \u2013 Afghanistan and Pakistan, 2009","volume":"59","year":"2010","journal-title":"MMWR"},{"issue":"4","key":"10.1016\/j.vaccine.2011.11.018_bib0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1377\/hlthaff.28.4.1091","article-title":"Diplomacy and the polio immunization Boycott in northern Nigeria","volume":"28","author":"Kaufmann","year":"2009","journal-title":"Health Affairs"},{"issue":"41","key":"10.1016\/j.vaccine.2011.11.018_bib0075","first-page":"1150","article-title":"Progress Toward Poliomyelitis Eradication \u2013 Nigeria, January 2008\u2013July 2009","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0080","unstructured":"Global Polio Eradication Initiative. Infected countries. http:\/\/www.polioeradication.org\/Infectedcountries.aspx (accessed 4.10.11)."},{"issue":"5","key":"10.1016\/j.vaccine.2011.11.018_bib0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1542\/peds.12.5.471","article-title":"Recent studies on immunization against poliomyelitis","volume":"12","author":"Salk","year":"1953","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0090","series-title":"Vaccines","article-title":"Alternative vaccine delivery methods","author":"Weniger","year":"2008"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0095","series-title":"Cellular biology; nucleic acids and viruses (Special Publications)","article-title":"Salk: control of polio with noninfectious vaccine","author":"von Magnus","year":"1957"},{"issue":"26","key":"10.1016\/j.vaccine.2011.11.018_bib0100","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0110","unstructured":"Hickling J, Jones R, Nundi N. Intradermal delivery of vaccines: A review of the literature and the potential for development for use in low- and middle-income countries, August 27, 2009. Program for Appropriate Technology in Health (PATH) and Working in Tandem, Ltd."},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.018_bib0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2011.11.018_bib0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4161\/hv.6.4.10961","article-title":"Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18\u201360 years: Randomized, controlled, phase III trial","volume":"6","author":"Arnou","year":"2010","journal-title":"Hum Vaccin"},{"issue":"12","key":"10.1016\/j.vaccine.2011.11.018_bib0125","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.vaccine.2009.01.043","article-title":"Intradermal hepatitis B vaccination: a systematic review and meta-analysis","volume":"27","author":"Sangare","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0130","unstructured":"Pasteur S. INTANZA\u00ae\/IDflu\u00ae, first intradermal influenza vaccine, approved in the European Union. http:\/\/en.sanofi.com\/press\/press_releases\/2009\/ppc_24214.asp (26.2.09)."},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.018_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0140_1","series-title":"Mucosal vaccines","article-title":"Polioviruses and Mucosal Vaccines","author":"Weaks-Levy","year":"1996"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0140_2","series-title":"Vaccines","article-title":"Alternative Vaccine Delivery Methods","author":"Weniger","year":"2008"},{"issue":"7042","key":"10.1016\/j.vaccine.2011.11.018_bib0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(58)90256-3","article-title":"Antibody response following intradermal or oral administration of formalinised poliomyelitis","volume":"2","author":"Connolly","year":"1958","journal-title":"Lancet"},{"issue":"7016","key":"10.1016\/j.vaccine.2011.11.018_bib0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(58)90989-9","article-title":"Response to poliomyelitis vaccination","volume":"1","author":"Sigurdsson","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0155","first-page":"143","article-title":"Observations on the immunizing effect of small doses of poliomyelitis vaccine inoculated by intradermal route in adult subjects","volume":"19","author":"Rosa","year":"1959","journal-title":"Riv Ital Ig"},{"issue":"30","key":"10.1016\/j.vaccine.2011.11.018_bib0160","article-title":"Correlazione tra intradermoreazione con antigeni poliomielitici ed anticorpi serici neutralizzanti","volume":"17","author":"Nigro","year":"1965","journal-title":"Miner Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.018_bib0165","first-page":"277","article-title":"Studies on the incidence and genetic characteristics of polioviruses during vaccination with polyvalent vaccines","volume":"33","author":"Jarzqbek","year":"1979","journal-title":"Przegl Epidemiol"},{"issue":"39","key":"10.1016\/j.vaccine.2011.11.018_bib0170","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1016\/j.vaccine.2008.07.026","article-title":"World wide experience with inactivated poliovirus vaccine","volume":"26","author":"Bonnet","year":"2008","journal-title":"Vaccine"},{"issue":"8763","key":"10.1016\/j.vaccine.2011.11.018_bib0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0140-6736(91)90480-D","article-title":"Immune response to intradermally injected inactivated poliovirus vaccine","volume":"338","author":"Samuel","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.018_bib0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0264-410X(92)90039-M","article-title":"Immune response of infants to inactivated poliovirus vaccine injected intradermally","volume":"10","author":"Samuel","year":"1992","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2011.11.018_bib0185","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0264-410X(97)00293-4","article-title":"Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine","volume":"16","author":"Nirmal","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.018_bib0190","first-page":"410","article-title":"Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21\u201322 September 2004","volume":"47","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.018_bib0195","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"issue":"8415","key":"10.1016\/j.vaccine.2011.11.018_bib0200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(84)90830-4","article-title":"Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine","volume":"2","author":"Salk","year":"1984","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:29Z","timestamp":1759400369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11017853"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal fractional dose inactivated polio vaccine: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}